USD10
OCS acciones
Acerca de Oculis HoldingOculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
USD10
OCS acciones
Acerca de Oculis HoldingOculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Estadísticas
VENTANA DE OPERACIÓN
Cerrado
ABRE A LAS
No hay suficientes datos
CAPITALIZACIÓN DE MERCADO
1441,49 M US$
PRECIO DE APERTURA
25,49 US$
BAJO (1Y)
14,00 US$
ALTO (1Y)
30,68 US$
BAJO (24H)
24,54 US$
Alza (24H)
26,01 US$
Volumen (24 h)
282,05 mil US$
40,43 %
Historial de precios
Time | Price | Change |
|---|---|---|
Hoy | 25,49 US$ | |
1 día | 24,86 US$ | 0,00 % |
1 semana | 26,26 US$ | |
1 mes | 28,36 US$ | |
1 año | 19,61 US$ |